N- and C-terminal substance P fragments modulate striatal dopamine outflow through a cholinergic link mediated by muscarinic receptors

Neuroscience

Volumn 73, Issue 4, 1996, Pages 919-927

  Khan, S ^a   Grogan, E ^a   Whelpton, R ^a   Michael Titus, A T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

acetylcholine; dopamine; muscarinic receptors; striatum; substance P; substance P fragments

Indexed keywords

ACETYLCHOLINE; ATROPINE; CHOLINESTERASE INHIBITOR; DIHYDRO BETA ERYTHROIDINE; DOPAMINE; HEMICHOLINIUM 3; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEOSTIGMINE; NICOTINIC RECEPTOR BLOCKING AGENT; PEMPIDINE; SUBSTANCE P; SUBSTANCE P [1-4]; SUBSTANCE P [1-7]; SUBSTANCE P [5-11]; SUBSTANCE P [6-11];

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CARBOXY TERMINAL SEQUENCE; CHOLINERGIC NERVE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029946109     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00119-4     Document Type: Article

References (77)

1. Anderson J. J., Chase T. N. and Engber T. M. (1993) Substance P increases release of acetylcholine in the dorsal striatum of freely moving rats. Brain Res. 623, 189-194.
2. Andrén P. E. and Caprioli R. M. (1995) In vivo metabolism of substance P in rat striatum utilizing microdialysis/liquid chromatography/micro-electrospray mass spectrometry. J. Mass Spect. 30, 817-824.
3. Arenas E., Alberch J., Perez-Navarro E., Solsona C. and Marsal J. (1991) Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum. J. Neurosci. 11, 2332-2338.
4. Bartfai T., Iverfelt K., Fisone G. and Serfozo P. (1988) Regulation of the release of coexisting neurotransmitters. A. Rev. Pharmac. Toxicol. 28, 285-310.
5. Baruch P., Artaud F., Godeheu G., Barbieto L., Glowinski J. and Chéramy A. (1988) Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopamine neurons. Neuroscience 25, 889-898.
6. Blumberg S., Teichberg V. I., Charli J. L., Hersch L. B. and McKelvy J. F. (1980) Cleavage of substance P to an N-terminal tetrapeptide and a C-terminal heptapeptide by a post-proline cleaving enzyme from bovine brain. Brain Res. 192, 477-486.
7. Bolam J. P., Ingham C. A., Izzo P. N., Levey A. I., Rye D. B., Smith A. D. and Wainer B. H. (1986) Substance P-containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrain: a double immunocytochemical study in the rat. Brain Res. 397, 279-289.
8. Bolam J. P., Somogyi P., Takagi H., Fodor I. and Smith A. D. (1983) Localization of substance P-like immunoreactivity in neurons and nerve terminals in the neostriatum of the rat: a correlated light and electron microscopic study. J. Neurocytol. 12, 325-344.
9. Clarke P. B. S. and Pert A. (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348, 355-358.
10. 11]-substance P. Brain Res. 531, 333-337.
11. De Belleroche J. and Bradford H. F. (1978) Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals. Brain Res. 142, 53-68.
12. De Klippel N., Sarre S., Ebinger G. and Michotte Y. (1993) Effect on M1 and M2 muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats. Brain Res. 630, 57-64.
13. DeBoer P. and Westerink B. H. C. (1994) GABAergic modulation of striatal cholinergic interneurons: an in vivo microdialysis study. J. Neurochem. 62, 70-76.
14. 1 receptor antagonist. Eur. J. Pharmac. 250, 403-413.
15. Gauchy C., Desban M., Krebs M. O., Glowinski J. and Kemel M. L. (1991) Role of dynorphin-containing neurons in the presynaptic inhibitory control of the acetylcholine-evoked release of dopamine in the striosomes and the matrix of the cat caudate nucleus. Neuroscience 41, 449-458.
16. 3H]substance P in rat cerebral cortex. Brain Res. 601, 34-40.
17. Gerfen C. R. (1991) Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556, 165-170.
18. Gerfen C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. A. Rev. Neurosci. 15, 285-320.
19. Gerfen C. R. and Young W. S. III (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460, 161-167.
20. Giorguieff M. F., Le Floc'h M. L., Glowinski J. and Besson M. J. (1977) Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat. J. Pharm. exp. Ther. 200, 535-544.
21. 3H]dopamine on rat striatal slices and cat caudate nucleus. Brain Res. 106, 117-131.
22. Giorguieff-Chesselet M. F., Kemel M. L., Wanscheer D. and Glowinski J. (1979) Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: effect of nicotine in a low concentration. Life Sci. 25, 1257-1262.
23. Guzman R. G., Kendrick K. M. and Emson P. C. (1993) Effect of substance P on acetylcholine and dopamine release in the rat striatum: a microdialysis study. Brain Res. 622, 147-154.
24. Hall M. E., Miley F. B. and Stewart J. M. (1989) Cardiovascular effects of substance P peptides in the nucleus of the solitary tract. Brain Res. 497, 280-290.
25. Herrera-Marschitz M., Terenius L., Sakurada T., Reid M. S. and Ungerstedt U. (1990) The substance P(1-7) fragment is a potent modulator of substance P actions in the brain. Brain Res. 521, 316-320.
26. Hersch S. M., Gutekunst C.-A., Rees H. D., Heilman C. J. and Levey A. I. (1994) Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J. Neurosci. 14, 3351-3364.
27. Heymann E. and Mentlein R. (1978) Liver dipeptidyl aminopeptidase IV hydrolyzes substance P. Fedn Eur. biochem. Socs Lett. 91, 360-364.
28. 2-terminus of substance P modulates NMDA-induced activity in the mouse spinal cord. J. Neurosci. 14, 3364-3369.
29. Humpel C. and Saria A. (1989) Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra. Neurosci. Lett. 105, 159-163.
30. Humpel C., Saria A. and Regoli D. (1991) Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism. Eur. J. Pharm. 195, 107-114.
31. Igwe O. J., Felice L. J., Seybold V. S. and Larson A. A. (1988) Optimization of high-performance liquid chromatography-radioimmunoassay protocols for the analyses of substance P and some of its metabolic fragments. J. Chromat. 432, 113-126.
32. Igwe O. J., Kim D. C., Seybold V. S. and Larson A. A. (1990) Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes. J. Neurosci. 10, 3653-3663.
33. Kaneko T., Shigemoto R., Nakanishi S. and Mizuno N. (1993) Substance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons. Brain Res. 631, 297-303.
34. Kato G., Carson S., Kemel M. L., Glowinski J. and Giorguieff M. (1978) Changes in striatal specific 3H-atropine binding after unilateral 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons. Life Sci. 22, 1607-1614.
35. 2 from bradykinin, by X-Pro dipeptidyl-aminopeptidase. Biochim. biophys. Acta 525, 417-422.
36. Kemel M. L., Desban M., Glowinski J. and Gauchy C. (1989) Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus. Proc. natn. Acad. Sci. U.S.A. 86, 9006-9010.
37. Kemel M. L., Desban M., Glowinski J. and Gauchy C. (1992) Functional heterogeneity of the matrix compartment in the cat caudate nucleus as demonstrated by the cholinergic presynaptic regulation of dopamine release. Neuroscience 50, 597-610.
38. Khan S., Brooks N., Whelpton R. and Michael-Titus A. T. (1995) Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum. Eur. J. Pharmac. 282, 229-233.
39. Khan S., Grogan E., Whelpton R. and Michael-Titus A. T. (1995) Substance P and its fragments (1-7) and (5-11) modulate striatal dopamine outflow via a cholinergic link mediated by muscarinic receptors. Br. J. Pharmac. 116, 96P.
40. Khan S., Whelpton R. and Michael-Titus A. T. (1996) Evidence for modulatory effects of substance P fragments (1-4) and (8-11) on endogenous dopamine outflow in rat striatal slices. Neurosci. Lett. 205, 1-4.
41. Khan S., Whelpton R. and Michael-Titus A. T. (1995) Endogenous dopamine outflow from rat striatal slices in static and dynamic conditions. Neurosci. Res. Commun. 16, 145-153.
42. Kudernatsch M. and Sutor B. (1994) Cholinergic modulation of dopamine overflow in the rat neostriatum: a fast cyclic voltammetric study in vitro. Neurosci. Lett. 181, 107-112.
43. Lee C. M., Sandberg B. E. B., Hanley M. R. and Iversen L. L. (1981) Purification and characterization of a membrane-bound substance P-degrading enzyme from human brain. Eur. J. Biochem. 114, 315-327.
44. Lindefors N., Brodin E., Tossman U., Segovia J. and Ungerstedt U. (1989) Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Exp. Brain Res. 74, 527-534.
45. Liu H., Brown J. L., Jasmin L., Maggio J. E., Vigna S. R., Mantyh P. W. and Basbaum A. I. (1994) Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors. Proc. natn. Acad. Sci. U.S.A. 91, 1009-1013.
46. Matsas R., Fulcher I. S., Kenny A. J. and Turner A. J. (1983) Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc. natn. Acad. Sci. U.S.A. 80, 3111-3115.
47. Matsas R., Kenny A. J. and Turner A. J. (1984) The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase 24.11. Biochem. J. 223, 433-440.
48. Mauborgne A., Bourgoin S., Benoliel J. J., Hirsch M., Berthier J. L., Hamon M. and Cesselin F. J. (1987) Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra. J. Pharmac. exp. Ther. 243, 674-680.
49. 2+-dependently endogenous 3,4-dihydroxyphenylalanine from rat striatal slices. Brain Res. 520, 334-337.
50. Nyberg F., Le Grèves P., Sundqvist C. and Terenius L. (1984) Characterisation of substance P(1-7) and (1-8) generating enzyme in human cerebrospinal fluid. Biochem. biophys. Res. Commun. 125, 244-250.
51. 3H-substance P binding sites in rat brain membranes. Peptides 5, 833-836.
52. Penny G. R., Afsharpour S. and Kitai S. T. (1986) The glutamic acid decarboxylase-, leucine-, enkephalin-, and substance P-immunoreactive neurons in the neostriatum of the rat and cat: evidence for partial population overlap. Neuroscience 17, 1011-1045.
53. 3H]dopamine from rat striatal slices: a tetrodotoxin-sensitive process. Neuropharmacology 25, 1015-1021.
54. Petitet F., Glowinski J. and Beaujouan J.-C. (1991) Evoked release of acetylcholine in the rat striatum by stimulation of tachykinin NK-1 receptors. Eur. J. Pharmac. 192, 203-204.
55. Raiteri M., Marchi M. and Maura G. (1982) Presynaptic muscarinic receptors increase striatal dopamine release evoked by "quasi-physiological" depolarization. Eur. J. Pharmac. 83, 127-129.
56. 3H]dopamine release from striatal synaptosomes: pharmacological characterisation. J. Neurochem. 54, 937-945.
57. Regoli D., Boudon A. and Fauchère J. L. (1994) Receptors and antagonists for substance P and related peptides. Pharmac. Rev. 46, 551-599.
58. Reid M. S., Herrera-Marschitz M., Hökfelt T., Lindefors N., Persson H. and Ungerstedt U. (1990) Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release; evidence for direct regulatory mechanisms. Exp. Brain Res. 82, 293-303.
59. Reid M. S., Herrera-Marschitz M., Terenius L. and Ungerstedt U. (1990) Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments. Brain Res. 526, 228-234.
60. Sakurada T., Le Grèves P., Stewart J. and Terenius L. (1985) Measurement of substance P metabolites in rat CNS. J. Neurochem. 44, 718-722.
61. Schulz D. W. and Zigmond R. E. (1989) Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum. Neurosci. Lett. 98, 310-316.
62. Schwartz R. D., Lehmann J. and Kellar K. J. (1984) Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain. J. Neurochem. 42, 1495-1498.
63. 3H]acetylcholine in rat brain. Molec. Pharmac. 22, 56-62.
64. Skidgel R., Engelbrecht S., Johnson A. R. and Erdös E. D. (1982) Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 3, 851-857.
65. Skilling S. R., Smullin D. H. and Larson A. A. (1990) Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception. J. Neurosci. 10, 1309-1318.
66. Stewart J. M., Hall M. E., Harkins J., Frederickson R. C. A., Terenius L., Hökfelt T. and Krivoy W. A. (1982) A fragment of substance P with specific central activity: SP(1-7). Peptides 3, 851-857.
67. 3H]captopril: localization to a striatonigral pathway. Proc. natn. Acad. Sci. U.S.A. 81, 1599-1603.
68. Tremblay L., Kemel M. L., Desban M., Gauchy C. and Glowinski J. (1992) Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2 and NK3 tachykinin receptors. Proc. natn. Acad. Sci. U.S.A. 89, 11,214-11,218.
69. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J. and Swanson L. W. (1989) Distribution of alpha 2, alpha 3, alpha 4 and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. comp. Neurol. 284, 314-335.
70. Waelbroeck M., Tastenoy M., Camus J. and Cristophe J. (1990) Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol. Pharmacol. 38, 267-273.
71. Wei J., Walton E. A., Milici A. and Buccafusco J. J. (1994) m1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. J. Neurochem. 63, 815-821.
72. Weiner D. M., Levey A. I. and Brann M. R. (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc. natn. Acad. Sci. U.S.A. 87, 7050-7054.
73. 3H-dopamine from rat brain slices. Neuropharmacology 13, 693-700.
74. 3H-dopamine by potassium and electrical stimulation from rat brain slices. Life Sci. 14, 1641-1652.
75. Xu M., Mizobe F., Yamamoto T. and Kato T. (1989) Differential effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Brain Res. 495, 232-242.
76. Xu M., Yamamoto T. and Kato T. (1990) In vivo striatal dopamine release by M1 muscarinic receptors is induced by activation of protein kinase C. J. Neurochem. 54, 1917-1919.
77. Yokosawa H., Endo S., Ogura Y. and Ishii S. (1983) A new feature of angiotensin-converting enzyme in the brain: hydrolysis of substance P. Biochem. biophys. Res. Commun. 116, 735-742.